Anemia in patients with heart failure and preserved systolic function

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.ahj.2005.03.056 Byline: G. Michael Felker, Linda K. Shaw, Wendy Gattis Stough, Christopher M. O'Connor Abstract: Anemia has been shown to be a predictor of mortality in patients with heart failure and impaired left ventricular systolic function (ISF). Although heart failure in the setting of preserved systolic function (PSF) is an important clinical problem, the relationship between anemia and outcomes in patients with PSF has not been carefully evaluated. Author Affiliation: Duke Clinical Research Institute, Durham, NC Article History: Received 12 November 2004; Accepted 30 March 2005 Article Note: (footnote) Dr Felker is supported in part by NIH K23 HL72357-01A1. This research was funded independently by the Duke Clinical Research Institute.